How Jonas Salk and Albert Sabin pioneered double-blind methodology, HeLa cell assays, and IBM data processing – innovations that became the global standard for clinical trials.
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
ON-DEMAND WEBINARS
Consider new perspectives on 2023-issued guidance by the EMA and FDA, and how the amalgamation of these directives, combined with scientific insights, can empower sponsors and biotech firms.
Learn how AI-enabled eCOA can reduce complexity in trial setup by cutting unnecessary meetings, speeding execution, and helping teams focus on what matters most.
Whether you're a sponsor, site, or technology vendor, now is the time to embrace One Home and join this industry-wide collaboration.
Discover how embracing fast and flexible clinical analytics can help you address clinical questions and provide real-time insights into data issues as they arise.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![digital-biomarkers-GettyImages-2246115813]( "Rewriting The Rules Of Clinical Trials Through Digital Biomarkers")
Rewriting The Rules Of Clinical Trials Through Digital BiomarkersDigital biomarkers are reshaping clinical research with continuous, real‑world data that enhances insights, accelerates timelines, and supports patient‑centric design. Explore how emerging tools, AI, and cross‑industry collaboration are driving smarter, more connected clinical development.
-
![domino effect and risk management concept iStock-1272805554]( "eCOA Risk Management In The Digital Age")
eCOA Risk Management In The Digital AgeRegulators across the globe are urging the industry to strengthen their data integrity practices. This article addresses the additional considerations that go hand in hand with the increased reliance on eSource data and the expansion of the electronic systems in clinical trials.
-
![GettyImages-1398569507 regulatory]( "5 Ways To Get Ready For IRT Regulatory Inspections")
5 Ways To Get Ready For IRT Regulatory InspectionsPreparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.
-
![GettyImages-1163698800 patient ePRO]( "Trends Shaping The Pharmaceutical Industry's Future")
Trends Shaping The Pharmaceutical Industry's FutureDecentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.
-
![GettyImages-1279248902 data links]( "How To Migrate Active Studies To A New EDC")
How To Migrate Active Studies To A New EDCGain access to the results and lessons learned from a project involving the modernization of an electronic data capture system and mid-study data migrations.
-
![iStock-1278931804-project-management-computer]( "4 Key Integrations For Your Clinical Trial Management System")
4 Key Integrations For Your Clinical Trial Management SystemDiscover how implementing a clinical trial management system (CTMS) can generate significant improvements to the way an organization understands their research portfolio, manages the financial components of trials, leverages reporting and analytics, and more.
-
![eConsent-Informed-tablet-iPad]( "How eConsent Can Help Legally Authorized Representatives")
How eConsent Can Help Legally Authorized RepresentativesSoftware vendors often forget to think about the needs of LARs, even though they play a vital role in clinical trials. Explore three ways eConsent can help LARs complete the informed consent process.
-
![GettyImages-1468430468_ai_clinical_trials]( "Break The Contracting Bottleneck To Speed Site Activation")
Break The Contracting Bottleneck To Speed Site ActivationWith the appropriate training data, AI has the capability to automate information gathering, document creation, and workflow management.
-
![GettyImages-179973335 budget]( "The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets")
The Crucial Role Of IRT/RTSM In Optimizing Drug Supply BudgetsExpand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.
-
![GettyImages-1424406254 email marketing]( "Email: The Gold Standard For Clinical Trials")
Email: The Gold Standard For Clinical TrialsAlthough non-verbal conversations between friends are now primarily conducted through text messages or similar apps, see why email remains the standard mode for businesses and organizations.
FROM THE EDITOR
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
- The Dream Is EHR-To-EDC — eSource Is The Wake-Up Call
- Synthetic Control Arms: When Data Stands In For Patients
- Paving The Way For Sites To Use Their Own Tech
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
- 01.22.26 -- The Role Of Open Source In Powering CDISC 360i
- 01.15.26 -- Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity